AMERICAN JOURNAL OF CARDIOLOGY, vol.92, no.8, pp.1007-1009, 2003 (SCI-Expanded)
Both aerosolized and intravenous infusion of iloprost caused a significant decrease in mean pulmonary artery pressure and pulmonary vascular resistance. Although intravenous infusion caused a large decrease in mean systemic arterial pressure, this was only slightly affected by aerosolized iloprost. Aerosolized iloprost caused a significant decrease in the pulmonary-to-systemic vascular resistance ratio; however, intravenous infusion did not cause a prominent decrease in this ratio. (C) 2003 by Excerpta Medica, Inc.